As COVID-19 infections rise again with the return of school, uncertainty looms over the availability of updated vaccines. Will high-risk individuals be the only ones to access them by mid-September?
In a surprising move, federal vaccine advisers have voted to remove thimerosal from flu shots, aligning with anti-vaccine activists. This decision raises concerns about vaccine availability and public health.
The US health department's new requirement for placebo testing on vaccines has sparked debate among experts, who warn it could slow vaccine access and raise ethical issues. What does this mean for your health?
In a surprising announcement, Health Secretary Robert F. Kennedy Jr. calls for placebo-controlled studies for all new vaccines, raising questions about existing protocols and the future of Covid vaccine availability.
In an unprecedented move, U.S. Senators express deep concerns over the FDA's cancellation of a critical VRBPAC meeting, risking vaccine availability during the worst flu season in 15 years. The senators demand accountability and clarity from nominee Dr. Marty Makary.
The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
